Uterine Fibroid Embolization (UFE)
Uterine fibroid embolization - The procedure is an alternative to hysterectomy and has a very high success profile as a treatment for bulk-related symptoms and bleeding related to fibroids. Our staff is very experienced in the UFE procedure and we tailor both care and follow-up to the needs of each patient. |
|
Overview:
- 20-40% of women 35 and older have fibroids of significant size
- Most frequent indication for hysterectomy in pre-menopausal women
- 600,000 hysterectomies performed annually in US; 1/3rd due to fibroids
- Most common tumor of the female genital tract
- Prevalence in female population of childbearing age: 30% or higher
- 10-20% of women with fibroids require therapy
Diagnosis
- Suspected on pelvic examination
- Confirmed with imaging (Ultrasound, MRI)
History
- Embolization first performed 30 years ago
- 1990's French gynecologist first requested uterine fibroid Embolization (UFE) prior to hysterectomy
- Introduced into the USA in 1995 by Drs. McLucas and Goodwin
- As of 2002, 20,000 UFE procedures performed worldwide
The Fertility Issue
- It is unclear how fertility is affected
- Multiple reports of successful pregnancies post embolization
- Large multi-center trial needed
- Myomectomy recommended for those wanting to preserve fertility
Child-bearing Age: Exceptions
- Poor candidate for myomectomy: fibroids are too large and/or numerous
- Failed myomectomy: symptoms reoccur or persist despite myomectomy
- Poor surgical candidate
Results
- Technical success: 98%
- >87% effective in reducing bleeding
- >93% effective in alleviating pain associated with fibroids
- Expected decrease in fibroid volume is 50%
- Patient satisfaction post UFE is 94%
Just the Facts..
- Fibroid reoccurrence is exceedingly rare
- UFE is not harmful to the uterus
- In the setting of multiple fibroids, all are treated
Pre-embolization Evaluation
- Gynecology evaluation.
- Routine pre-angiography blood work
- Pelvic MRI or ultrasound for baseline sizing and localization of lesions
- Yearly pap smear
- Endometrial biopsy if bleeding is the primary problem
How Does It Work?
- Two uterine arteries supply the uterus
- Tiny microspheres decrease blood flow to these hypervascular tumors
- Starvation of fibroids results in shrinkage
- UFE Procedure
- Procedure time: 1.5 hrs
- Patient asleep throughout entire procedure
- Normal activity in 5-7 days
- Procedure performed in radiology suite
- Patient comfort is a high priority
- Overnight observation for pain control.
- Discharged to home the following morning
Post-Procedure Management
- Routine overnight admission for pain control
- Discharge after 24 hours
Expected Clinical Course
- Pelvic pain and discomfort which should progressively decrease and resolve over 2 weeks
- Fibroid size decreases over several months time
Uterine Cramping
- All will experience a certain degree of uterine cramping following embolization.
- Low grade cramping for up to 2 weeks; "roller-coaster" like.
Cost
- Equivalent to cost of hysterectomy or open myomectomy
- Covered by most insurances
Conclusion
- Uterine artery embolization is safe and effective for alleviating symptoms from fibroid disease
- >87% success at decreasing or resolving heavy bleeding or pressure symptoms
- >93% effective in reducing pain
- 94% patient satisfaction
- Effect on future fertility has not been thoroughly studied
 Call for an appointment and mention that you found us on the web.
Arnot Ogden Medical Center, Elmira NY, 607-737-4148
St. Joseph's Hospital, Elmira New York, 607-737-7813
Find more information at: Ask For UFE
Find more information at: National Uterine Fibroids Foundation
Find more information at: Society of Interventional Radiology
|
